Pricing Log in Create free account

Actuate Therapeutics, Inc. (ACTU) vs Citius Pharmaceuticals, Inc. (CTXR)

Actuate Therapeutics, Inc. and Citius Pharmaceuticals, Inc. are both Biotechnology companies. Actuate Therapeutics, Inc. and Citius Pharmaceuticals, Inc. are of similar size ($12.6M and $12.0M). Across the 10 metrics below, Actuate Therapeutics, Inc. leads on 7 and Citius Pharmaceuticals, Inc. on 3.

Valuation

Metric ACTU CTXR Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 14.72 0.16 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (142.62%) (372.09%) (33.15%)
Free cash flow yield (136.22%) (289.71%) (25.50%)

Profitability

Metric ACTU CTXR Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 2,457.65% (64.51%) (56.36%)
Return on assets (336.18%) (34.29%) (48.04%)
Return on invested capital 0.00% (58.74%) 0.00%

Growth

Metric ACTU CTXR Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 67.48% 43.38% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ACTU CTXR Biotechnology median
Debt to equity 0.00 0.08 0.00
Current ratio 1.25 0.84 4.72
Net debt to EBITDA 0.59 0.11 0.96

Dividend

Metric ACTU CTXR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ACTU CTXR Biotechnology median
Market cap 12.01m 12.63m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack